Windtree Therapeutics Announces Late-Breaker Presentation on Phase 2 SEISMiC Study Results of Istaroxime in Early Cardiogenic Shock at the European Society of Cardiology (ESC) Heart Failure Conference
Company to host conference call following the presentation WARRINGTON, Pa., April 20, 2022 (GLOBE NEWSWIRE)…